All InsightsDownload This Document
Download This Document
In this 2019 Life Sciences Quick Reference Guide, you will gain access to proprietary insights including:
Earnout Achievement Overview, including Bio/Pharma and Devices and Dx/Research
Timeline of Paid Milestones, including:
- Bio/Pharma Milestone Achievement by Developmental Phase
- Negotiated Milestone Dollars by Developmental Phase
- Devices and Dx/Research Milestone Achievement by Product Stage
Median Indemnification Escrow/Holdback Size
Earnout Disputes and Renegotiations
SRS Acquiom has provided professional and financial services on over 225 life sciences M&A transactions since 2008, involving biotech/pharmaceutical products, medical devices, diagnostics, and life sciences tools and technologies. Very few of these agreements are available publicly, nor is information on post-closing outcomes.
To download the reference guide, complete the form below.
Don Morrissey
Head of Life Sciences 303.250.8936
Don advises life science clients on M&A deal negotiations and post-closing milestones and earnouts. He is principal author of our life science studies and a frequent speaker at industry events.
Before joining SRS Acquiom, Don spent more than a decade helping to grow two venture-backed life science start-up companies through IPOs. He has been responsible for many strategic transactions involving licensing, partnering and M&A, as well as financings with leading venture capital and private equity firms. He was formerly SVP, Corporate Development and General Counsel for Replidyne, an antibiotic drug development company, and VP, Legal Affairs and Business Development for Caliper Life Sciences, a microfluidics company. He began his career as a business attorney with Cooley LLP.
Don holds a law degree from USC and a BA in Molecular, Cellular and Developmental Biology from the University of Colorado.